The challenge to realize the full market potential of a medical technology is increasing every day. Only 12% of med-tech ventures generate significant returns to investors, and 50% fail despite seasoned leadership and sufficient funding.(1)

Despite millions of dollars invested annually in the development of hundreds of medical technologies, only a handful of them ever generate more than a billion dollars in annual sales. Nonetheless, it seems most med-tech companies claim to represent a "billion dollar opportunity." Why the disconnect?

Dymedex has pioneered the application of the scientific method to medical technology market development. We have developed proven thought-leading tools to rigorously quantify realizable revenue potential, objectively assess the barriers to full adoption, and accurately forecast future growth rates.

How can Dymedex help you?

  • Market Analysis: In-depth analysis of a medical technology's realizable annual revenue potential and revenue forecast based on a comprehensive assessment of market size, drivers of adoption, technology attractiveness, and planned investments
  • Strategic Consulting: Strategic evaluation and prioritization of opportunities by facilitating the strategic planning process, offering extensive context for business decisions, providing independent evaluations of existing strategies, and assessing acquisition candidates
  • Education and Training: Market development training and seminars geared to both leaders and mid-level managers, helping organizations increase the impact of internal market development investments to drive market growth
  • Revenue Acceleration: Trouble-shoot medical products that have failed to achieve projected revenue targets, providing new insights and actionable plans to re-establish sustainable growth
  • Execution Support: Detailed market development plans across 5 year, 12 month, and quarterly horizons that link growth strategies directly to implementation

For a high-level overview of Dymedex, see our two-page brochure or contact us for a free 90 minute in-house mini-class on The Science of Market Development.

(1) Patient Capital, National Venture Capital Association's Medical Industry Group, at www.nvca.org ↑

Market Development is a unique marketing discipline that focuses on defining and delivering the full potential of a medical technology.

Dymedex applies scientific method principles to market development, which has proven to maximize market adoption, growth rates, and ROI.